-       Report 
- April 2025
-  175 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
          -       Report 
- October 2025
-  281 Pages 
- Global 
   From       €5233EUR$5,850USD£4,603GBP 
          -       Report 
- October 2025
-  575 Pages 
- Global 
   From       €5233EUR$5,850USD£4,603GBP 
            -       Report 
- June 2024
-  200 Pages 
- Global 
   From       €5689EUR$6,360USD£5,004GBP 
      €7111EUR$7,950USD£6,255GBP 
                 -       Book 
- December 2015
- North America 
                  Endocrine tumors are a type of cancer that originate in the endocrine system, which is responsible for producing hormones that regulate the body's metabolism, growth, and development. Endocrine tumors can be benign or malignant, and can affect any of the endocrine glands, including the pituitary, thyroid, parathyroid, adrenal, and pancreas. Symptoms of endocrine tumors vary depending on the type and location of the tumor, but can include weight gain or loss, fatigue, changes in appetite, and changes    in hormone levels. Treatment options for endocrine tumors include surgery, radiation therapy, and chemotherapy.
There are a number of companies that specialize in the development of treatments for endocrine tumors. These include Novartis, Pfizer, Merck, and Bristol-Myers Squibb. Additionally, there are a number of smaller companies that are developing treatments for endocrine tumors, such as ImmunoGen, Inc., and OncoSec Medical Incorporated. Show Less   Read more